John Wiley and Sons offers an attractive valuation at a forward price-to-earnings ratio near 9x with analyst upside over 50%, but heavy concentration in its research segment and an imminent earnings event create binary risk that warrants waiting before establishing a new position.
Thesis pillars
- Attractive Valuation Low Peg→Stable
- Earnings Beat Streak→Stable
- Research Segment Concentration Risk↑Improving
- +1 more pillar — see the Why tab for full reasoning
John Wiley & Sons, Inc. (WLY) Stock Analysis
Communication Services · Publishing
Hold if already holding. Not a fresh buy at $49.55, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Negative news sentiment (-0.67).
John Wiley & Sons is a global research and learning publisher operating through two primary segments: Research, which generated 64% of consolidated revenue in fiscal 2025 through over 1,800 scientific and scholarly journals, and Learning, which generated 35% through academic,... Read more
Hold if already holding. Not a fresh buy at $49.55, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Negative news sentiment (-0.67). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.3/10, moderate confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 40d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.
About John Wiley & Sons, Inc.
About John Wiley & Sons, Inc.
John Wiley & Sons publishes more than 1,800 peer-reviewed scientific, technical, and scholarly journals through its Research segment, which generated approximately 64% of fiscal 2025 consolidated revenue, while its Learning segment of academic and professional books, courseware, and assessments contributed roughly 35%. Operations span the United States, United Kingdom, Sri Lanka, Germany, and India, with about 49% of consolidated revenue earned outside the US, and 83% of adjusted revenue coming from digital products and services.
Research revenue comes from Journal Subscriptions and Transformational Agreements sold directly to research institutions and library consortia under multi-year contracts, Open Access publishing fees paid by authors or their funders, and licensing revenue that increasingly includes fees from AI developers training models on Wiley's content. Approximately 46% of Journal Subscriptions revenue derives from publication rights owned by professional societies and other partners under long-term or jointly-owned contracts, with royalties paid back to those societies. The Learning segment sells print and digital textbooks, courseware such as WileyPLUS and zyBooks, and professional assessments through bookstores, online retailers, and direct-to-student channels, distributing digital titles through intermediaries including Amazon, Apple, and Google. Wiley owns no printing facilities and has outsourced US book distribution operations to Cengage Learning, reflecting a broader shift toward variable-cost, asset-light production and distribution.
Show full overview
Wiley's Research segment carries a funding-policy dependency the 10-K flags directly: proposed reductions in US federal funding for the National Institutes of Health and Department of Education could constrain library and university customers' ability to renew journal subscriptions, even though Wiley's geographic revenue distribution provides some offsetting diversification. A separate, less-diversifiable exposure sits in content supply — approximately 30% of articles published in Research during calendar year 2024 included China-based authors, comparable to the roughly 32% industry rate, while Chinese institutions have begun compiling early-warning lists of foreign journals carrying high volumes of China-authored content, a screening practice that could constrain future submission volume from that market.
See also: Communication Services · Publishing
From John Wiley & Sons, Inc.'s most recent 10-K filing, extracted July 26, 2026.
Recent developments
updated 2026-07-26Recent Developments — John Wiley & Sons, Inc.
Latest news
- NEWS John Wiley & Sons Inc (WLY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey — TradingKey neutral
- NEWS Earnings Preview: WLY to Report Financial Results on June 16 - 富途牛牛 — 富途牛牛 neutral
- NEWS Earnings Preview: WLY to Report Financial Results on June 16 - Moomoo — Moomoo neutral
- NEWS Crude oil down 5%; John Wiley & Sons shares fall after Q4 results - MSN — MSN negative
- NEWS Is John Wiley & Sons Inc (WLY) Overvalued After 4.1% Rally? GF V - GuruFocus — GuruFocus neutral
Generated 2026-07-27T15:03:03Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographicoutside the US49%10-K Item 1: 'In the year ended April 30, 2025, approximately 49% of our consolidated revenue was from outside the US.'
- HIGHProductResearch segment64%10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMcounterpartyprofessional societies46%10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners'
- MEDIUMGeographicChina-based authors30%10-K Item 1A: 'approximately 30% of the articles we published in calendar year 2024 included China-based authors'
Material Events(8-K, last 90d)
- 2026-05-06Item 5.02MEDIUMJay Flynn, EVP and GM of Research and Learning, departed without cause; Jessica Kowalski was appointed EVP and GM of Research effective May 11, 2026. Kowalski joins from Microsoft with prior roles at AWS and RELX.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $49.55, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Negative news sentiment (-0.67). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $57.80 (+16.6%), stop $46.08 (−7.5%), A.R:R 1.9:1. Score 6.3/10, moderate confidence.
Take-profit target: $57.80 (+16.6% upside). Target $57.80 (+16.6%), stop $46.08 (−7.5%), A.R:R 1.9:1. Stop-loss: $46.08.
Concentration risk — Product: Research segment (64.0%); Negative news sentiment (-0.67); Negative momentum.
John Wiley & Sons, Inc. trades at a P/E of 11.7 (forward 9.3). TrendMatrix value score: 9.1/10. Verdict: Hold.
5 analysts cover WLY with a consensus score of 4.0/5. Average price target: $68.
What does John Wiley & Sons, Inc. do?John Wiley & Sons is a global research and learning publisher operating through two primary segments: Research, which...
John Wiley & Sons is a global research and learning publisher operating through two primary segments: Research, which generated 64% of consolidated revenue in fiscal 2025 through over 1,800 scientific and scholarly journals, and Learning, which generated 35% through academic, professional and assessment publishing. The company is predominantly digital, with 83% of fiscal 2025 Adjusted Revenue from digital products, 48% recurring, and approximately 49% of consolidated revenue generated outside the United States.